Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

China Resources Sanjiu Medical & Pharma (000999.SZ)

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (Rmb) Price Target (Rmb) Rating
2020-12-2824.5138.00Buy
2021-01-2026.1136.75Buy
2021-08-2426.4837.50Buy
2022-03-2839.4147.00Buy
2023-02-0348.04-No Rating
2023-02-2051.0661.00Buy
2023-08-0952.6065.00Buy
2023-08-3147.5859.00Buy
2023-10-3044.4255.00Buy

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day.